NewsRx

Search our medical news database

Disease Transmission

Project aims to develop microbicides to protect women against HIV

Published in Anti-Infectives Week, April 12th, 2004

While condom use remains the most effective protection against sexual transmission of HIV, it is clear that in many parts of the world women are not empowered to insist on it.

The urgent need for novel strategies to block HIV-1 transmission is being recognized by an Europe-wide consortium, the European Microbicides Project (EMPRO), led by King's College London and funded by the European Commission.

The project aims to develop new microbicides containing molecules that block the virus' ability to attach itself to the genital mucosal surfaces. With HIV infection soaring and the absence of a protective vaccine, these products are urgently needed.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Anti-Infectives Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook